NPSP558 proven effective in Hypoparathyroidism: NPS study
NPSP558 is the company’s bioengineered replica of human parathyroid hormone (rhPTH 1-84), which received orphan drug status for the treatment of hypoparathyroidism. REPLACE was a 28-week, double-blind, placebo-controlled
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.